> The suggestion we sell to other countries to make more money is not right because we make no profit everywhere.That's the approach we took and we agreed on that. That’s the agreement we have with Oxford University. It's actually even written in a contract we have with Oxford University: that we will be at no profit. We have slightly different prices from one geographic to the other because the cost of goods may be different. We have a supply chain in Brazil, we have another one in Latin America, another one in South Asia. We have one in Japan. Of course, you know, local costs are different. So you've got slight variations, but more or less, it's about three to four dollars, more or less everywhere.This was an interview with the AZ CEO when the EU delays first kicked off: https://www.repubblica.it/cronaca/2021/01/26/news/interview_...
The core difference for the EU contract was that the EU wouldn't accept any/as-much liability for any harm caused by the vaccine (compared with UK/USA). Not sure the source of this claim.
No comments yet.